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Several indirect lines of evidence have con-
verged to suggest that Corynebacterium aenes
is a major source of the lipolytic enzymes re-
sponsible for the formation of diglycerides,
monoglycericles, and free fatty acids in human
surface lipid by cleavage of fatty acids from
the triglycerides of newly formed sebum. These
include: A. The recent demonstration that
sebum isolated from intact human sebaceous
glands contains no monoglycerides, diglycerides,
or free fatty acids (1) ; B. The earlier demon-
stration that lipids isolated from steatocysto-
mas, presumably representing sebum unexposed
to sebaceous gland ducts, contained no free
fatty acids (2) ; and C. The demonstration
that antibacterial therapy, either topical (3) or
systemic (4) results in clear cut suppression of
lipoItic activity and a striking reduction in
the concentratioii of the free fatty acids of
human surface lipid, which may be mediated
by suppression of C. acnes, the predominant
organism in pilosebaceous follicles, and one
highly sensitive to tetracycline (5).
The present preliminary study was under-
taken to determine directly whether C. acnes
possesses lipolytic enzymes capable of hydrolyz-
ing triglycerides to release diglycerides, mono-
We should like to express our appreciation to
Miss Badryeh Cummings for her invaluable tech-
nical assistance.
We would also like to extend our special appre-
ciation to Dr. George Rouser, Senior Research Bio-
chemist and Chief, Section of Lipid Research, City
of Hope, Duarte, California, for his generous ad-
vice and counsel on analytic methods, and his gen-
erous permission to allow us to use his unpub-
lished technique for the identification of free fatty
acids by thin layer chromatography. We should
also like to express our appreciation to Dr. Gene
Kritchevsky, Research Associate in Chemistry,
City of Hope, Duarte, California, for his generous
advice and counsel on analytic methods.
* From the Department of Medicine, Division of
Dermatology, Harbor General Hospital, Torrance,
California 90509,t and the Department of Medi-
cine. Division of Dermatology, UCLA School of
Medicine, Los Angeles, California 90024t
Supported in part by Grant AM 11164 from the
National Institute of Arthritis and Metabolic Dis-
eases, in part by a grant from The Elliot and Ruth
Handler Foundation, and in part by a grant from
The Max Factor Memorial Fund.
Accepted for publication April 24, 1968.
190
glycerides, and free fatty acids. For this initial
study, five short to long chain saturated tri-
glycerides were chosen—tricaprylin, tricaprin,
trilaurin, trimyristin, and tripalmitin—and two
unsaturated triglycerides—tripalmitolein and
triolein.
MATERIALS
1. Thin layer chromatography plates—silica
gel, pre-coated, abrasion resistant, 20 X 20 cm
from Brinkman Instrument, Inc., Westbury, New
York.
2. 2',7'-dichlorofluorescein from Eastman Or-
ganic Chemicals.
3. 2,2, 4-trimethylpentane (iso-octane), b. 98.55—
9950 C. and iso-propyl acetate, b. 86.5—88.5° C.
both from Matheson, Colman, and Bell.
4. Chloroform and methanol-reagent grade from
Merck.
5. (a) Triglycerides—tricaprylin, tricaprin, tn-
laurin, trimyristin, tripalmitin, tripalmitolein and
triolein. (b) Diglycerides—dimyristin, dipalmitin,
and diolein. (c) Monoglycerides—monomyristin,
monopalmitin and monoolein. (d) Fatty Acids—
caprylic, capric, lauric, myristic, palmitic, pal—
mitoleic, and oleic. All from Applied Science
Laboratories, Inglewood, California. All lipid
sttndards were prepared in glass distilled chloro-
form: methanol (2:1 v/v).
'tETHODS
A basal medium was prepared for use in all
growth studies. This consisted of 1% peptone
(Bacto) and 0.5% yeast extract (Difco) in dis-
tilled water. Medium was distributed in 2 ml
amounts into ether rinsed screw cap test tubes,
and autoclaved at 15 lbs. pressure for 15 min-
utes.
All triglycerides were rechecked for purity in
our laboratory by thin layer chromatography be-
fore further use. Tricaprylin, tripalmitolein, and
triolein, all liquids at room temperature, were
incorporated in the amount of 2 mg of tri-
glyceride per 2 ml tube of room temperature
medium. Those triglycerides which are solid at
room temperature—tricaprin, trilaurin, trirny-
ristin, and tripalmitin, were first suspended in
acetone at room temperature, and then added
dropwise to boiling medium to a total amount of
2 mg of triglyceride per 2 ml tube of medium.
Fresh cultures of C. acnes grown on Brain
Heart Infusion agar (Bacto) were used as inocula.
Organisms were harvested and washed twice with
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sterile distilled water. The suspensions were
standardized with distilled water to a final opti-
cal density of 0.61 in the Coleman Jr. spectro-
photometer at 420 lambda. One tenth ml of C.
aenes suspension was inoculated into each tube.
Controls of sterile basal media without triglyc-
erides, sterile basal media with triglycerides, and
inoculated basal media without triglycerides were
included in each experiment. Tubes were incu-
bated anaerobically at 37 degrees centigrade for 6
days.
Following incubation, the culture tubes were
agitated to obtain even dispersion, and the con-
tents transferred to glass stoppered extraction
tubes. Five volumes of chloroform: methanol
(2:1) were then added to each extraction tube.
After vigorous shaking for approximately 2 min-
utes, the tubes were centrifuged and the aqueous
portion discarded. The residual organic solvent
phase was transferred to a clean glass stoppereci
tube, and stored for approximately four hours at
15° C. We have noted that this step greatly
facilitates removal of unwanted aqueous residues
and yields clean, clear solvent phases.
The solvent was then evaporated at room
temperature in a stream of nitrogen to a volume
of approximately 0.1 ml. This was streaked on
TLC plates.
The one dimensional plates were developed
first in iso—octane:isopropyl acetate (50:30) un-
til the solvent front was approximately 2 cm
from the top of the plate. The plate was then
removed and air dried for 15 minutes. It was
then re—run in the same solvent system to the
same solvent front. The two dimensional plates
were developed first in chloroform 95, methanol
5, and ammonia .08 until the solvent front
moved within 4 cm of the top of the plate. The
plate was then dried at room temperature for
15 minutes and turned 900 and developed in
chloroform 8, acetone 1.5, methanol 0.25, acetic
acid 025, and water 0.8 until the solvent front
was within 4 cm of the top of the plate.
In the one dimensional plates, one lane of each
plate consists of known standard lipid compo-
nents for identification. Additional lanes were run
for extracts of media alone; extracts of individual
triglycerides and media mixed; and extracts of
bacteria and media mixed, to serve as controls
for the experimental lanes in which extracts of
FIG. 1. TLC plate #XII—bacterial and media control
0—origin, SF—solvent front
Lane 1—Sterile basal medium after incubation
Lane 2—Basal medium plus C. aenes after incubation
Lano 3—Basal medium plus C. acnes after incubation
Lane 4—Standard: trimyristin—100 meg (TG), dimyristin—100 meg (DG), mono-
myrmstin—100 mcg (MG), myristic acid—100 rncg (FFA), and lecithin—100 rncg (0)
doubly developed in iso-octane: iso-propyl acetate, (50:30).
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Fic. 2. TLC plate #11—incubation of C. aenes with tricaprylin
O—ongin, HF—solvent front
Lane 1—Basal medium plus tricaprylin after incubation
Lane 2—Basal medium plus tricaprylin plus C. acnes; after incubation.
Lane 3—Standard: tricaprylin—100 meg (TG), caprylie acid—100 meg (FFA), lecithin
100 meg (0), monornyristmn 100 meg (MG) and dirnyristmn 100 meg (DG)
doubly developed in iso-octane:iso-propyl acetate, (50:30),
the tubes of media in which bacteria were grown
in the presence of triglyceride were run.
Plates were then sprayed with 0.2% 2',7' di-
ehlorofluorescein in ethanol for visualization of
the lipids, and photographed in ultraviolet light
in the Chromato-Vue made by Ultraviolet Light
Products of San Gabriel, California, utilizing
Kodalith Ortho film at f 5.6 for 10 seconds, and
developed for 1 minute in Dektol.
RESULTS
Unless otherwise specifically noted, extracts
cited in the results section of this paper
are chloroform methanol (2:1) extracts, and all
TLC plates are doubly developed in iso-
octane: isopropyl acetate (50:30).
TLC Plate XII pictured it Figure 1 demon-
strates the abseime of free fatty acids in ex-
tracts of sterile basal media and basal media
inoculated with C. acnes, thus serving as a
control observation for the experimental plates
in wInch various triglycerides have been in-
corporated iflto basal media innoculated with
C. acnes. A stationary, nonfluorescent unidenti-
fled spot is present at the point of origin in all
lanes containing media. A nonfluorescing, un-
identified dark spot migrating at the rf of
diglyceride is present in all lanes containing
(1. acnes. FFA are absent in sterile basal media
(lane 1) and in basal media itmoculated with
C. acnes (lane 2 and 3). The lipid standards
(lane 4) move in ascending order as follows:
phospholipids (0), monoglycerides (MG),
free fatty acids (FFA), diglycerides (DG),
with the characteristic double spot represent-
ing the 1,3 and 1,2 structures, and triglycer-
ides (TG).
TLC plate II shown in Figure 2 demon-
strates the lipolytic capacity of C. acnes acting
on a saturated, relatively short chain triglycer-
ide, tricaprylin, to release a free fatty acid.
There is also an as yet uiidentified fluoresceit
spot migrating just above the FFA spot.
TLC plate IV shown in Figure 3 is another
representative plate demonstrating the capacity
of C. aenes to hydrolyze a longer straight chaii
saturated triglyceride trilaurin, to release free
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FIG. 3. TLC plate IV—incubation of C. ocnes with
trilaurin 0—origin SF—solvent front
Lane 1—Basal medium plus trilaurin after incubation
Lane 2—Basal medium plus trilaurin plus C. acnes, after incubation
Lane 3—Standard: trilaurin 100 meg (TG), laurie aeid—100 meg (FFA), lecithin—
100 meg (0), monomyristin—100 meg (MG), dimyristin—100 meg (DG)
doubly developed in iso-octane:iso-propyl acetate, (50:30).
fatty acid. The, leading edge of the FFA spot
in lane 2 migrates beyond the FFA standard.
Our TLC studies with mixtures of free fatty
acids leads us to believe that this pattern of
migration probably represents a mixture of
laurie acid with other free fatty acids of shorter
chain length. Since only pure trilaurin was
introduced into the system originally, this
would further suggest the possibility that en-
zymes are present which further degrade in-
dividual free fatty acids to produce compo-
nents of shorter chain lengths. The evaluation
of this problem is being undertaken by gas
chromatograpinc study.
TLC plate VIII shown in Figure 4 demon-
strates the lipolytic capacity of C. aenes in
liberating free fatty acid from a. longer straight
chain unsaturated triglyceride, tripalmitolein.
The presence of a fluorescent spot in lane 2
migrating at the rf of the lower of the double
diglyceride standard, suggests the possibility
that in this experiment, the lipolytie enzymes
available from C. aenes were insufficient to
completely hydrolyze all fatty acid molecules
from the glycerol skeleton, thus leaving some
molecules from which only one free fatty acid
had been cleaved, resulting in the presence of a
diglyceride.
Thin layer plate XIII, Figure 5 demon-
strates a two dimensional method developed
by Dr. George Rouser (6) for the rapid de-
termination of the presence of a free fatty
acid. A known standard mixture of tripalmitin,
dipalmitin, monopalmitin, palmitie acid, and
lecithin, in amounts of 100 meg each is dis-
solved in chloroform: methanol (2:1) streaked
and developed as described in Methods. FFA
remains stationary in the first dlevelopnlent,
and migrates in the second, appearing just to
the left of 5. An unidentified non-fluorescent
spot appears just below 3.
Utilizing this method, spots corresponding to
the FFA standard were scraped off one di-
mensional TLC plates, extracted with chloro-
form: methanol (2:1) and the identity of the
FFA confirmed by two dimensional chromatog-
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Fio. 4. TLC plate VIII—ineubation of C. oenes with
tripalmitolein, 0—origin, SF—solvent front
Lano 1—Basal medium plus tripalmitolein after incubation
Lane 2—Basal medium plus tripalmitolein plus C. ocaes, after incubation
Lane 3—Standard: tripalmitolein—100 meg (TG), palmitoleie aeid—100 meg (FFA),
leeithin—lOO meg (0), monopalmitm—lOO meg (MG), and dipalmitin—i00 meg(DG)
doubly developed in iso-octane: iso-propyl acetate, (50:30).
raphy. TLC plate XIV, Figure 6 shows the
identification of the FFA spot from an extract
of hasal medium with added trimyristin in—
noculated with C. acmcs. Several unidentified
nonfluoreseent spots are noted.
In addition to the representative TLC plates
shown in Figures 2, 3, 4, in which the effect of
the incubation of C. acncs with trieaprylin,
trilaurin, and tripalmitolein in releasing free
fatty acids from triglycerides was demon-
strated, similar experiments with trieaprin,
tripalmitm, trimyristin, and triolein, were car-
ried out with similar results. In each case, free
fatty acids were clearly shown to be liberated
from the pure triglycerides after incubation
with C. ocacs.
alseussloN
This preliminary study has clearly demon-
strated the capacity of C. ocncs to cleave in
vitro a series of triglycerides resulting in the
liberation of free fatty acids. The triglycerides
chosen in this initial study were five short to
long straight chain saturated triglycerides and
two straight chain unsaturated triglycerides.
The studies reported in this paper arc with a
single strain of C. ocncs isolated from a pa-
tient with acne. The possibility that various
strains may possess differing lipolytie activity
in vitro under the conditions of this experi-
ment, and might thus possibly have different
degrees of pathogenicity in terms of acne gene-
sis is presently being explored. In view of the
probable differing degrees of irritaney of
various free fatty acids, and to further estab-
lish the precise lipolytie patterns of C. acncs,
further studies utilizing gas chromatography to
analyze in detail the free fatty acids identified
by TLC arc being developed.
While this initial study clearly demonstrates
the lipolytic activity of C. ocncs, additional
studies are needed to determine the relative
significance of this source of lipolytie enzyme
in the sebaeeous duet and the piloscbaccous
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Fjo. 5. TLC plate XIII—free fatty acid identification, standards, after two dimensional
development
0—origin SF—solvent front
A. direction of first development with chloroform—OS, methanol—5, and ammonia—
0.8
B. direction of second development with chloroform—8, aeetone—l.5, methanol—
025, acetic acid—0.25, and water .08
I—lecithin, 100 meg
2—monopalmitin, 100 meg
3—dipalmitin, 100 meg
4—tripalmitin, 100 meg
5—palmitie acid, 100 meg
follicle, as opposed to those derived from other
organisms present, including Pityrosporum
species, Demodex follieulorum, and other bac-
teria, particularly the other major resident
organisms present in acne, coagulase-negative
Staphylococcus albus, as well as endogenous
lipolytic enzymes, if any.
However, there is evidence suggesting that
C. acnes is an important source of the lipolytic
activity in the sebaceous duct and the pilo-
sebaceous follicle. As noted previously (4) the
administration of tetracycline systemically re-
sults in a striking reduction in the concentra-
tion of free fatty acids in scbum which can be
correlated with improvement of clinical acne.
This reduction in the concentration of free fatty
acids is well established by the end of the 3rd
week of tetracycline therapy. Upon discontinua-
tion of therapy, there is a trend toward re-
sumption of pre-treatment levels of free fatty
acids. This trend is evident during the first 3
week period after cessation of treatment.
These observations correlate well with the 2
weeks required for the marked drop in the
density of C. acnes (and S. albus) observed
after the initiation of tetracycline therapy, and
with the 2 weeks required for the return to
normal density after discontinuation of tetra-
cycline therapy (7). These observations, cou-
pled with the present evidence for the lipolytic
activity of C. Genes would strongly suggest that
C. ocnes is an important source of lipolytic
activity in the sebaeeous duct and pilosebaeeous
follicle. Further study is now under way to
evaluate the role of other microorganisms.
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Fio. 6. TLC plate XTV—frae fatty acid identification, unknown, two dimensional
development system
0—origin SF—solvent front
A. direction of first development with chloroform—95, methanol—5, and ammonia—
0.8
B. direction of second development with chloroform—8, aeetone—1.5, methanol—0.25,
acetic acid—025, and water .08
1. site of application of chloroform:methanol (2:1) extract of scraping of spot
in experiioental lane of TLC plate whose migratIon corresponded with FFA
standard
2. final position of material applied at 1, after two dimensional developioent,
demonstrating identity as a free fatty acid
SUMMARY
('orynebocterium acnes has been demon-
strated to have the capacity to cleave tri-
glycerides in vitro, resulting in the liberation
of free fatty acids. Thus, direct experimental
confirmation is given to the previously in-
ferred role of C. acnes as a source of lipolytic
activity of the sehaceous duct and pilosehaccous
follicle.
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